Yulong Eco-Materials Ltd

PINK:YECO USA Biotechnology
Market Cap
$879.38K
Market Cap Rank
#41197 Global
#13395 in USA
Share Price
$0.09
Change (1 day)
+0.00%
52-Week Range
$0.09 - $0.09
All Time High
$11.75
About

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to m… Read more

Yulong Eco-Materials Ltd (YECO) - Net Assets

Latest net assets as of June 2025: $-1.98 Million USD

Based on the latest financial reports, Yulong Eco-Materials Ltd (YECO) has net assets worth $-1.98 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($475.43K) and total liabilities ($2.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-1.98 Million
% of Total Assets -416.87%
Annual Growth Rate N/A
5-Year Change -126.04%
10-Year Change -104.25%
Growth Volatility 371.89

Yulong Eco-Materials Ltd - Net Assets Trend (2012–2024)

This chart illustrates how Yulong Eco-Materials Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Yulong Eco-Materials Ltd (2012–2024)

The table below shows the annual net assets of Yulong Eco-Materials Ltd from 2012 to 2024.

Year Net Assets Change
2024-12-31 $-1.98 Million -17.74%
2023-12-31 $-1.68 Million +87.83%
2022-12-31 $-13.83 Million -291.71%
2021-12-31 $7.22 Million -5.19%
2020-12-31 $7.61 Million +422.28%
2019-12-31 $1.46 Million -96.55%
2017-12-31 $42.23 Million +1035.65%
2016-12-31 $3.72 Million -38.28%
2015-12-31 $6.03 Million -87.08%
2014-12-31 $46.65 Million +23.92%
2013-12-31 $37.65 Million +40.16%
2012-12-31 $26.86 Million --

Equity Component Analysis

This analysis shows how different components contribute to Yulong Eco-Materials Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1934.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $10.22K %
Other Comprehensive Income $3.62 Million %
Other Components $43.71 Million %
Total Equity $-1.98 Million 100.00%

Yulong Eco-Materials Ltd Competitors by Market Cap

The table below lists competitors of Yulong Eco-Materials Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yulong Eco-Materials Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -1,683,355 to -1,981,925, a change of -298,570.
  • Net loss of 298,570 reduced equity.
  • Other comprehensive income decreased equity by 298,570.
  • Other factors increased equity by 298,570.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-298.57K -15.06%
Other Comprehensive Income $-298.57K -15.06%
Other Changes $298.57K +15.06%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Yulong Eco-Materials Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 $14.00 $0.09 x
2013-12-31 $24.53 $0.09 x
2014-12-31 $19.65 $0.09 x
2015-12-31 $2.53 $0.09 x
2016-12-31 $1.54 $0.09 x
2017-12-31 $17.52 $0.09 x
2019-12-31 $0.23 $0.09 x
2020-12-31 $1.05 $0.09 x
2021-12-31 $1.00 $0.09 x
2022-12-31 $-1.91 $0.09 x
2023-12-31 $-0.16 $0.09 x
2024-12-31 $-0.19 $0.09 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yulong Eco-Materials Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -167.40%
  • • Asset Turnover: 0.38x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-84.40%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 37.41% 23.66% 0.74x 2.13x $7.36 Million
2013 28.40% 24.05% 0.64x 1.85x $6.93 Million
2014 18.60% 18.77% 0.60x 1.66x $4.01 Million
2015 -882.67% -124.73% 1.26x 5.63x $-53.79 Million
2016 -199.78% -78.15% 0.29x 8.95x $-7.80 Million
2017 -1.31% -5.82% 0.16x 1.40x $-4.78 Million
2019 -6.75% 0.00% 0.00x 21.24x $-244.12K
2020 -1.30% 0.00% 0.00x 1.19x $-860.03K
2021 -5.37% -326.07% 0.00x 4.34x $-1.11 Million
2022 0.00% 0.00% 0.00x 0.00x $-19.67 Million
2023 0.00% -2591.28% 0.11x 0.00x $-1.10 Million
2024 0.00% -167.40% 0.38x 0.00x $-100.38K

Industry Comparison

This section compares Yulong Eco-Materials Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $59,082,939
  • Average return on equity (ROE) among peers: -341.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yulong Eco-Materials Ltd (YECO) $-1.98 Million 37.41% N/A $93.35K
Aadi Bioscience Inc (AADI) $-124.24K 0.00% 0.00x $17.03 Million
America Great Health (AAGH) $-992.37K 0.00% 0.00x $2.12 Million
Ascentage Pharma Group International (AAPG) $70.63 Million -1310.51% 34.40x $2.25 Billion
Aardvark Therapeutics, Inc. Common Stock (AARD) $-27.92 Million 0.00% 0.00x $59.18 Million
ABIVAX Société Anonyme (AAVXF) $196.01 Million -75.37% 0.67x $377.86 Million
Abcellera Biologics Inc (ABCL) $10.25 Million -21.57% 1.29x $738.02 Million
Abeona Therapeutics Inc (ABEO) $489.00K -1919.02% 38.85x $202.79 Million
Acumen Pharmaceuticals Inc (ABOS) $188.78 Million -22.70% 0.04x $108.65 Million
Abpro Holdings, Inc. (ABP) $-22.46 Million 0.00% 0.00x $2.00 Million
Absci Corp (ABSI) $176.18 Million -62.76% 0.23x $345.85 Million